Developing Bispecific T cell Engagers Against pHLA Targets in Oncology and Beyond

• Identification of novel pHLA targets using 3T-TRACE – an integrated experimental and computational platform
• Development of highly bispecific T cell engagers against pHLA in oncology
• Application of target discovery outside of oncology in autoimmunity

Speakers:

Marvin Gee

Co-Founder & Chief Research Officer

3T Biosciences